Clinical Trial: A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Study Status: Completed
Recruit Status: RECRUITING
Condition: Carcinoma, Squamous Cell of Head and Neck
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects With Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2
Brief Summary:
This clinical trial is studying advanced or metastatic solid tumors.Once a solid tumor has grown very large in one spot or has spread to other places in the body, it is called advanced or metastatic cancer.Participants in this study must have head and neck squamous cell cancer, non-small cell lung cancer, endometrial cancer, or ovarian cancer.Participants must have tumors that have a marker called HER2.This clinical trial uses an experimental drug called disitamab vedotin (DV).DV is a type of antibody-drug…
Read more